Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

导出原文传递

翻译打印收藏纠错

作者： Tonneijck, Lennart ^[1] ; Smits, Mark M. ^[2] ; Muskiet, Marcel H. A. ^[3] ; Hoekstra, Trynke ^[4] ; Kramer, Mark H. H. ^[5] ; Danser, A. H. Jan ; ter Wee, Piet M. ; Diamant, Michaela ; Joles, Jaap A. ; van Raalte, Daniel H.

作者单位： Erasmus Univ, Med Ctr, Div Pharmacol & Vasc Med, Dept Internal Med, Rotterdam, Netherlands ^[1] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Ctr Diabet, Amsterdam, Netherlands ^[2] Univ Med Ctr, Dept Nephrol & Hypertens, Utrecht, Netherlands ^[3] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands ^[4] Vrije Univ Amsterdam, Med Ctr, Dept Nephrol, Amsterdam, Netherlands ^[5]

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Diabetes care

2016年39卷11期

2042-2050页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Diabetes care

相似文献

Diabetes care

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Diabetes care

相似文献

Diabetes care

相关期刊

检索历史清除